US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, UNIVERSITY OF MARYLAND, BALTIMORE, THE MCLEAN HOSPITAL, THE REGENTS OF THE UNIVERSITY OF MICHIGAN on Aug. 26 for "Methods of using muscarinic antagonists in the treatment of depression" (Maryland, Texas, Michigan, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,988, issued on Aug. 26, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas), UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore), THE MCLEAN HOSPITAL Corp. (Belmont, Mass.) and THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.).

"Methods of using muscarinic antagonists in the treatment of depression" was invented by Andrew Coop (Columbia, Md.), Chad R. Johnson (Baltimore), Jack Bergman (Cambridge, Mass.), Brian D. Kangas (Boston), James H. Woods (San Antonio), Emily M. Jutkiewicz (Dexter, Mich.) and Gail Winger (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Muscarinic antagonist are provided that ar...